These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15447982)

  • 1. Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes.
    Jones C; Ford E; Gillett C; Ryder K; Merrett S; Reis-Filho JS; Fulford LG; Hanby A; Lakhani SR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5988-97. PubMed ID: 15447982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution.
    Buerger H; Mommers EC; Littmann R; Simon R; Diallo R; Poremba C; Dockhorn-Dworniczak B; van Diest PJ; Boecker W
    J Pathol; 2001 Jun; 194(2):165-70. PubMed ID: 11400144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH.
    Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Welzl G; Höfler H; Werner M
    Int J Cancer; 2000 Jan; 85(1):82-6. PubMed ID: 10585588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
    Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
    Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast.
    Marchiò C; Iravani M; Natrajan R; Lambros MB; Savage K; Tamber N; Fenwick K; Mackay A; Senetta R; Di Palma S; Schmitt FC; Bussolati G; Ellis LO; Ashworth A; Sapino A; Reis-Filho JS
    J Pathol; 2008 Aug; 215(4):398-410. PubMed ID: 18484683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetics of primary breast cancer by CGH.
    Tirkkonen M; Tanner M; Karhu R; Kallioniemi A; Isola J; Kallioniemi OP
    Genes Chromosomes Cancer; 1998 Mar; 21(3):177-84. PubMed ID: 9523192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer in young women (< or = 35 years): Genomic aberrations detected by comparative genomic hybridization.
    Weber-Mangal S; Sinn HP; Popp S; Klaes R; Emig R; Bentz M; Mansmann U; Bastert G; Bartram CR; Jauch A
    Int J Cancer; 2003 Nov; 107(4):583-92. PubMed ID: 14520696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.
    Fulford LG; Reis-Filho JS; Ryder K; Jones C; Gillett CE; Hanby A; Easton D; Lakhani SR
    Breast Cancer Res; 2007; 9(1):R4. PubMed ID: 17217540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients.
    Aubele M; Auer G; Braselmann H; Nährig J; Zitzelsberger H; Quintanilla-Martinez L; Smida J; Walch A; Höfler H; Werner M
    Anal Cell Pathol; 2002; 24(2-3):77-87. PubMed ID: 12446957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas.
    Zudaire I; Odero MD; Caballero C; Valenti C; Martínez-Penuela JM; Isola J; Calasanz MJ
    Histopathology; 2002 Jun; 40(6):547-55. PubMed ID: 12047766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.
    Rakha EA; El-Rehim DA; Paish C; Green AR; Lee AH; Robertson JF; Blamey RW; Macmillan D; Ellis IO
    Eur J Cancer; 2006 Dec; 42(18):3149-56. PubMed ID: 17055256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization analysis of invasive ductal breast carcinomas in the Chinese population.
    Zhang J; Zhang H; Xu X; Wang M; Yu Z
    Oncol Lett; 2015 Oct; 10(4):2100-2106. PubMed ID: 26622803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma.
    James LA; Mitchell EL; Menasce L; Varley JM
    Oncogene; 1997 Mar; 14(9):1059-65. PubMed ID: 9070654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic hybridization (CGH) analysis of chromosomal aberrations in Iranian patients with invasive ductal carcinoma breast cancer.
    Ghaffari SR; Sabokbar T; Pour PN; Dastan J; Mehrkhani F; Shoraka S; Mohagheghi MA; Tirgari F; Mosavi-Jarrahi A
    Asian Pac J Cancer Prev; 2008; 9(1):66-70. PubMed ID: 18439077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.
    Jones C; Nonni AV; Fulford L; Merrett S; Chaggar R; Eusebi V; Lakhani SR
    Br J Cancer; 2001 Aug; 85(3):422-7. PubMed ID: 11487275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic markers in triple-negative breast cancer.
    Rakha EA; El-Sayed ME; Green AR; Lee AH; Robertson JF; Ellis IO
    Cancer; 2007 Jan; 109(1):25-32. PubMed ID: 17146782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
    J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.